ArticleVeterinary world2025
Echocardiographic assessment of left ventricular function in mules under general anesthesia induced with a high-dose xylazine-based protocol.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Echocardiographic effects of medetomidine, butorphanol, and their combination in donkeys.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Echocardiographic assessment in equines is typically performed on standing animals; however, no studies have evaluated left ventricular function in anesthetized mules using high-dose xylazine. Given the unique pharmacokinetics in mules and their higher anesthetic requirements, this study aimed to assess the effects of acepromazine-xylazine-diazepam-ketamine anesthesia, using the upper limit xylazine dose (1.6 mg/kg), on the left ventricular size and function in mules. Materials and Methods: Six healthy adult mules (18.83 ± 0.75 years; 263.83 ± 39.34 kg) were evaluated using standard two-dimensional and M-mode transthoracic echocardiography. Measurements were obtained before sedation (standing) and 13-min post-anesthetic induction (dorsal recumbency). Each mule received an intravenous injection of acepromazine (0.04 mg/kg), xylazine (1.6 mg/kg), diazepam (0.1 mg/kg), and ketamine (2.2 mg/kg). Key echocardiographic parameters included interventricular septum thickness (interventricular septum in diastole and interventricular septum in systole), left ventricular internal diameters (left ventricular internal diameter in diastole and left ventricular internal diameter in systole [LVIDs]), posterior wall thickness (left ventricular posterior wall in diastole and left ventricular posterior wall in systole), ejection fraction (EF), and fractional shortening (FS). Statistical comparisons were made using paired t-tests and Wilcoxon signed-rank tests (p < 0.05). Results: Heart rate, EF, and FS significantly decreased post-anesthesia (p < 0.01), indicating reduced systolic function. Specifically, LVIDs increased from 4.60 ± 0.65 cm to 6.26 ± 0.48 cm (p < 0.01), while no significant changes were observed in diastolic parameters or respiratory rate. Anesthetic induction was smooth and graded as good to excellent in all cases. Conclusion: High-dose xylazine significantly suppressed systolic cardiac function in anesthetized mules without causing arrhythmias or bradyarrhythmia. The combination protocol was effective and provided safe anesthesia induction, with echocardiography proving feasible under dorsal recumbency. These findings support the cautious use of upper-limit xylazine dosing in mules and suggest echocardiographic monitoring as a valuable tool during anesthesia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.